Making a Measurable Difference

Published Online: Saturday, June 1, 2002

As more disease management programs enlist pharmacists in the management of patients with diabetes, cost-benefit analyses are beginning to show significant savings.

According to a recent study published in the Journal of Managed Care Pharmacy, the VA Medical Center in Pittsburgh found that patients with type 2 diabetes who were enrolled in its pharmacist-based program experienced significant improvements in glycemic control within 6 months.The estimated net savings was more than $103,000 per year for 15 of the most severely ill patients.And in Asheville, NC, a network of community pharmacists saved the city more than $900 per diabetes patient per year. Elsewhere, evaluations of community pharmacists? diabetes-related interventions have put the 1 time cost savings from the prevention of hospitalizations or unnecessary office visits at $4,295 per patient.

Latest Articles
Pharmacists might be surprised to learn that Pinterest is a hotbed for anti-vaccine sentiment.
The FDA has approved betamethasone dipropionate spray, 0.05%, as a treatment for mild to moderate plaque psoriasis in patients aged 18 years and older.
Medication errors injure thousands of patients annually, and while mistakes occur with all medication classes, those involving antiretroviral therapies are particularly troublesome.
Acute respiratory infections such as the common cold are often accompanied by cough and congestion caused by mucus hypersecretion.
Latest Issues